 In this video, we'll go through top five penny stocks with up to a $20 price target. These are what some of the analysts are saying. They're saying that some of these penny stocks could be worth up to $20. Okay, and we'll go through the research. We'll go through the information. I'm gonna get right into the video and right into the information. If you appreciate the direct approach, then please leave a like on the video. It really helps out the channel. Let's get right into the information. I've got to say I'm not a financial advisor. I am a business teacher in my daily life, but I'm by no means an expert on the stock market. So let's go through these top five ones that I've got for you today. So first of all, we've got nine meters biopharma. Now, who are they? So nine meters biopharma is a rare and unmet need focused GI company. The company is advancing drug candidates for short bowel syndrome and celiac disease. Okay, so it's a biopharmaceutical company. It's involved in this area. Now, what do the analysts say? So the analysts actually have this particular stock at, well, it's trading at $1.60 at the moment, $1.60. It's run up a little bit. And the analysts have, this is a price target of a low of $3, a medium of $5, okay, and a high of $5. So that means that this analysts, the collection of analysts feel that this stock is undervalued, fairly undervalued at the minute. So this could be a potential investment opportunity. Obviously, I'm not gonna go through the full depth of each company. Otherwise, it would be a 50 minute video. I just want to put some stocks onto your radar to possibly consider and looking into. So that is the first one that we've got for you today. Before we move on to the others, I've got to say thank you everybody for all the support on the channel. The channel's been growing massively, okay? And it would be amazing if we could get to 4,000 subscribers as fast as possible. That'd be fantastic. Honestly, everybody's been supporting the channel. Everybody's been liking the videos and making sure that they're reaching to the YouTube algorithm. And it really helps the channel out a lot. So thank you for everybody who's doing that. The next one we've got for you is called Mustang Bayer, ticker symbol M-B-I-R. Now, who are they? So Mustang Bayer, our recent medical breakthroughs in cell and gene therapy and have signaled a coming revolution in the patient care for previously untreatable disease. We at Mustang Bayer are translating through breakthroughs into next generation therapies. And then you can see the different ones there. So again, another Bayer soup, Bayer company here. And let's see what the analysts are saying for this one, right? So we've got $4.22. And the analysts actually have, on the low end, they have this at $7. On the medium, they have it at $11.50 and on the high in $13. Okay, this is in the next 12 months. It's currently trading at $4.22. Okay, so this stock has got a lot of potential to run up from its current level. It may be one worth getting into. Again, if it's the high of $13, that's almost a 300% increase. Okay, which is a massive amount here. So I just want to put this again onto your radar. The next one I've got for you, I've talked about this one before in depth in terms of what the company does. So I'm just going to put this into some information for you. And I'm not going to go right into the company. So what we got here, so it's at $1.99. Okay, and the five analysts, what do they say? They've got it on the low at $3, a medium of $5.50 and a high of $10. Five analysts. So again, this is another company that according to the analysts is underpriced and there's got a lot of potential. That is CLRB, ticker symbol CLRB. I personally got a position in this stock. I think that it's got a lot of potential. I've looked at the website, looked at the research that they're doing. And I think that it's got a lot of potential. Do look into it yourself, see what you think. Okay, I'm just putting some on your radar. Some you might have already heard of, some you might not. The next one we've got for you is Polattery TE, which ticker symbol is PTE, okay? What are they? So who are this company? So they are, they construct intended to being used by fans, by physicians or other appropriate healthcare providers for the repair, replacement, reconstruction or supplement of skin tissue and into gumatory systems, okay? So this particular stock is very interesting. I think that this has got a lot of demand for this particular type of product, right? I'm looking into this one and I'm really considering this one personally. I'm just looking for the best price on this. So what are we at? It's at 0.81, okay? 0.81 and there's three analysts that have it a low of $3, a medium of $3 and a high of $3. So that's almost, that's over triple what its current price point is. So this is considered grossly undervalued by the analysts. The company itself seems quite good in terms of the demand for the sort of products that they're producing there. And what I would say is, if you can get this at a lower level, get it at a dip at 0.60, 0.65, that might be a potential buying opportunity, okay? The next one we've got here is Orchard Therapeutics, okay? So who are they? So Orchard was founded in 2015, but our roots run deeper going back to some of the first research and clinical development involving ex vivo autologous gene therapy. We're proud of our scientists have played a central role in the evolution of technology from a bold vision to a potentially life-transforming reality. Today we carry forward the history and rigor of science, curiosity, discovery and commitment to families affected by rare diseases. So this one is another company in this particular sector, right? And what is it sat at? So it's sat at $6.47. The analysts on this one are just like, wow, you know, they're saying that this stock is incredibly undervalued. So the eight analysts have a price target here of a low of $9, a medium of $14.50 and a high of $20. It's currently sat at $6.47. Again, grossly underpriced according to the analysts. Again, this is in the next 12 months. This is where they see this stock going. This is not next week, okay? This is in the next 12 months. But, you know, maybe if it could reach, say for example, if it's on its way to its high of $20 in 12 months, if it can reach up to $9, right? At this lower level within the next sort of three to six months, that's still a really, really good increase on this stock. But again, if it's this high of $20, that is an immense increase, okay? That is incredible profit gains on that one. So that's what that's one we've got for you there. And I've got a bonus here. Everybody knows about Galaxy Next Generation by now. If you've been following my channel, Gaxi, ticker symbol, G-A-X-Y. I've got to say I've recently watched an interview from the owner of this company. I'm going to make another dedicated video on this because I've got some more interesting news and interesting thoughts for this company. What I would suggest people to do is to start a small, you can do what you want. I'm not a financial advisor, business teacher, but I'm not a financial advisor. I would build out your position on this stock, okay? This stock is going to go very well, in my opinion. I could be wrong, but I think that this has got a lot of potential to go up a lot of very fast, very quickly, and it's going to go up quite a lot, in my opinion, okay? So look into Galaxy Next Generation. What do they do? They produce educational solutions in schools, and also they're involved in corporate events, and when you talk about ed tech, they talk about there in the education technology sector, right? What people tend to think about is just schools, right? But actually, they're trying to get into other industries as well. So Gaxi is an interesting one because it's not just schools. It's like corporate events and training in corporate events because you've got to think you've got training programs, haven't you, in organizations where people are being educated, right? There's a lot of education tools that can be used in these training development ones, but I'm going to go into this in a more in-depth video on Galaxy, but build out your position on this stock. There's a lot of potential. Or at least do some research, or put it on your watch list, on this particular one, because I think this has got a lot of potential, as in micro-penis, right? Okay, so I'll end the video with my stock thought of the day, which is strategy, okay? You've got to think about what your strategic decisions are going to be. So what does that mean? So you've got to think about when you're going to be buying in, and you can set your own buying prices, right? And you've got to think about when you're looking to take profits on stocks. You've also got to determine whether your stocks are long-term or short-term. Are you holding some of these stocks for the long-term? Are you holding them for the short-term for a quick swing trade? You've got to be really clear on your strategy. Why? Because you need to be adaptable. Sometimes the market froze you a curve ball, right? And you've got to adapt to that situation. And a good kind of example is a game of chess, right? You've got to always be adaptable. You've got to make the moves that you need to make, right? So consider that. Thanks for watching the video. Don't forget to leave the video a like to get it right up into those YouTube algorithms. It's much appreciated. If you're new to the channel, then please subscribe. We cover many stocks and many penny stocks. So I'd appreciate if you could subscribe. And I'll see everybody in the next video.